|
|
|
Corporate Profile: ImmuCell
| Summary: |
From its
inception in 1982, ImmuCell Corporation has engaged
in the research and development of both infectious
disease diagnostic tests and products for therapeutic
and preventive uses against certain infectious diseases
in both animals and humans. Since 1991, this product
development effort has focused more principally
on the prevention and treatment of gastrointestinal
infections. Beginning in 1998, ImmuCell Corporation
narrowed its development focus to primarily animal
health products. |
| Address (HQ):
|
56 Evergreen Drive
Portland, ME 04103 |
| Phone #'s (HQ): |
Main |
(207) 878-2770 |
| Human Resources |
not known |
| Investor Relations |
(207) 878-2770 |
| Fax #'s (HQ): |
Main |
(207) 878-2117 |
| Human Resources |
not known |
| Investor Relations |
(207) 878-2117 |
| Financial
information: |
| ICCC |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
